M. Engelhard
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 20
- Oncology 13
- Viral-associated cancers and disorders 4
- Neutropenia and Cancer Infections 3
- Co-authors
- P. Meusers (6 shared papers)D. Huhn (7 shared papers)W. Siegert (6 shared papers)K. Lennert (5 shared papers)Günter Brittinger (4 shared papers)Markus Tiemann (4 shared papers)Wolfgang Hiddemann (6 shared papers)Eva Hoster (3 shared papers)
- Journals
- Blood (2 papers)Strahlentherapie und Onkologie (2 papers)Annals of Oncology (2 papers)British Journal of Haematology (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
M. Engelhard
37 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 69
- Pathology and Forensic Medicine 657
- Genetics 233
- Oncology 500
- Internal Medicine 61
- Dermatology 106
Countries citing papers authored by M. Engelhard
This map shows the geographic impact of M. Engelhard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Engelhard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Engelhard more than expected).
Fields of papers citing papers by M. Engelhard
This network shows the impact of papers produced by M. Engelhard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Engelhard. The network helps show where M. Engelhard may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Engelhard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 292 | |
| 2 | 1993 | 115 | |
| 3 | 2007 | 96 | |
| 4 | Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. | 1997 | 90 |
| 5 | 1995 | 89 | |
| 6 | 1992 | 89 | |
| 7 | 1995 | 85 | |
| 8 | 2012 | 32 | |
| 9 | 2013 | 32 | |
| 10 | 1990 | 29 | |
| 11 | 2016 | 25 | |
| 12 | 2012 | 25 | |
| 13 | 2018 | 24 | |
| 14 | 1993 | 24 | |
| 15 | 2009 | 20 | |
| 16 | A cross-reaction between beta2-microglobulin and kappa-light chains. | 1977 | 18 |
| 17 | Clinical relevance of granulocyte-macrophage colony-stimulating factor. | 1994 | 17 |
| 18 | 1997 | 13 | |
| 19 | 1994 | 13 | |
| 20 | 1994 | 13 |
About M. Engelhard
M. Engelhard is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Genetics and Molecular Biology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (20 papers), Glycosylation and Glycoproteins Research (4 papers), Viral-associated cancers and disorders (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immune Cell Function and Interaction (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (657 citations), Genetics (233 citations), Oncology (500 citations), Internal Medicine (61 citations) and Dermatology (106 citations). M. Engelhard has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include P. Meusers, D. Huhn, W. Siegert, K. Lennert, Günter Brittinger, Markus Tiemann, Wolfgang Hiddemann, Eva Hoster, Martin Dreyling and G. Brittinger. Their work appears in journals such as Blood, Strahlentherapie und Onkologie, Annals of Oncology, British Journal of Haematology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.